• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMOBCT INC. SPECTRA OPTIA IDL SET; SEPARATOR, AUTOMATED, BLOOD CELL, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMOBCT INC. SPECTRA OPTIA IDL SET; SEPARATOR, AUTOMATED, BLOOD CELL, DIAGNOSTIC Back to Search Results
Lot Number 1806283330
Device Problems Leak/Splash (1354); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/27/2018
Event Type  Injury  
Event Description
The pt had car t cells collected for kymriah manufacturing.At the end of the collection, the nurse sealed the bag appropriately and left it hanging on the iv pole on the spectra optia device.She turned away to complete other tasks and when she turned back to the product, noted that most of it had leaked from the collection bag via the sterile barrier filter line.She immediately tightened the blue cap on the end of the line and slid the slide clamp to obstruct the line.The line has a frangible that must be activated in order to use the line to inject anticoagulant and this had not been activated.She was under the impression that if the frangible was not activated, fluid could not be added or removed from the collection bag.Terumobct was contacted, (b)(4) was the representative who received the call.She informed me that fluid could possibly leak via the sterile barrier filter line even if the frangible was intact.She recommended making sure the slide clamp is used on the line during set up and to ensure the blue cap on the end of the line is secure.The staff has been educated regarding the process and our sop will be updated accordingly.Terumobct did not feel it was necessary to return the collection bag to them and it was disposed of per their recommendation.Therapy start date: (b)(6) 2018.Therapy end date: (b)(6) 2018.Reason for use: used for stem cell collections.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA IDL SET
Type of Device
SEPARATOR, AUTOMATED, BLOOD CELL, DIAGNOSTIC
Manufacturer (Section D)
TERUMOBCT INC.
MDR Report Key7934038
MDR Text Key123072934
Report NumberMW5080331
Device Sequence Number0
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Device Operator No Information
Device Expiration Date06/01/2020
Device Lot Number1806283330
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/03/2018
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number0
Patient Outcome(s) Hospitalization;
Patient Age61 YR
Patient Weight59
-
-